BioNTech SE (NASDAQ:BNTX) is one of the best healthcare stocks to buy with highest upside potential. BioNTech SE (NASDAQ:BNTX ...
BRUSSELS, June 11 (Reuters) - The European Commission's appeal against a 2024 ruling forcing it to disclose information about ...
Is BNTX a good stock to buy? We came across a bullish thesis on BioNTech SE on r/ValueInvesting by birdflustocks. In this ...
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
BERLIN (Reuters) -BioNTech will invest 40 million euros ($43 million) in a new facility in Germany that will allow it to produce an important building block in mRNA-based drugs, the German ...
View BioNTech SE Sponsored ADR BNTX stock quote prices, financial information, real-time forecasts, and company news from CNN.
BioNTech’s ASCO Runway: Dual Cancer Data, a Shifting Analyst Pulse, and a Cash-Rich Pause for Growth
BioNTech sails into ASCO with two clinical readouts that underscore its pivot toward oncology beyond vaccines, even as the stock trades under mid-year pressure and investors weigh the pace of the ...
BioNTech SE has agreed to acquire British artificial intelligence (AI) startup InstaDeep for up to 562 million pounds ($682 ...
On Wednesday, BioNTech SE (NASDAQ:BNTX) agreed to acquire Biotheus, a clinical-stage biotechnology company focused on discovering and developing antibodies for oncological or inflammatory diseases.
The company’s financial buffer remains formidable: €16.76 billion in cash and marketable securities. Yet even as BioNTech pours money into its cancer programs, it is simultaneously slimming down its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results